Abstract
The sponsor is highly relevant in the conduct of clinical trials, both from a financial point of view and in terms of responsibility for study management. Until now, only one sponsor was designated as the primary contact for the conduct of clinical trials. The new regulation (EU) No 536/2014 allows the use of multiple sponsors, so-called co-sponsors. But this also raises new problems and questions for existing contracts and new contracts between sponsors, especially regarding the liability of one or more co-sponsors in the external as well as the internal relationship. This article highlights the issues arising from this amendment and clarifies the differences between a sponsor and a co-sponsor.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
